Eli Lilly says experimental drug slows decline from Alzheimer’s
If approved, Donanemab has annual multi-billion-dollar sales potential. Lilly shares rose 6% in early-afternoon trading.
Pharmaceutical
Articles
Shortages of prescription drugs growing in United States
There were 301 active national drug shortages through this year’s first quarter, according to the University of Utah Drug Information Service. That’s 49% higher than the 202 recorded in the first three months of 2018.
Powerful new obesity drug poised to upend weight-loss care
If approved for weight loss, Eli Lilly’s tirzepatide could become the most effective drug to date in an arsenal of medications that are transforming the treatment of obesity, which affects more than 4 in 10 American adults and is linked to dozens of diseases.
Purdue lands $100M for cancer drug Pluvicto royalties
Purdue University plans to use the funding to further support research at the university.
Drug manufacturer grows amid contracting boom
Fishers-based INCOG Biopharma Services Inc., one of the newest players in the $132 billion contract drug manufacturing industry, acts as a behind-the-scenes player for companies that need to get sterile injectable medicines to market in a hurry.
Supreme Court temporarily extends access to abortion pill
The court extended women’s access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication’s Food and Drug Administration approval continues.
Lilly to invest another $1.6 billion in Boone County site, add 200 jobs
The expansion will bring Eli Lilly and Co.’s total investment in the project to $3.7 billion, the most the company has ever spent on a single manufacturing site.
Indiana legislators OK over-the-counter birth control bill
The Indiana House bill is key to providing women quicker access to contraceptives, bill sponsor Republican Sen. Sue Glick said Tuesday, especially in areas where they struggle to receive primary care.
Texas judge suspends FDA approval of abortion pill mifepristone
A federal judge in Texas blocked U.S. government approval of a key abortion medication Friday, siding with abortion foes in an unprecedented lawsuit and potentially upending nationwide access to the pill widely used to terminate pregnancies.
Court overturns attorney fees award in case between ex-pharmacist, Pharmacy Board
A pharmacist convicted of producing and distributing adulterated drugs was not entitled to attorney fees in his case against the Indiana Board of Pharmacy, which was entitled to immunity, the Court of Appeals of Indiana has ruled.
Purdue lands $20M gift to develop leaders for pharmacy industry
The donation comes from the former CEO of Santa Barbara Specialty Pharmacy, which services California and five nearby states.
Lebanon planners approve Eli Lilly manufacturing site in Boone County
The Lebanon Plan Commission voted unanimously Monday to approve Eli Lilly and Co.’s development plan for its two manufacturing facilities in Boone County.
Fishers biotech firm lands additional FDA approval for imaging product
Illuccix was first approved by the FDA in December 2021. The imaging agent is designed to target and “light up” cancerous cells, making it easier for oncologists to determine through a PET scan if the cells have spread to areas outside the prostate.
COVID-19 pill Paxlovid moves closer to full FDA approval
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.
Lilly’s older Alzheimer’s drug fails to prevent disease in trial
Eli Lilly said the study concludes its clinical development of solanezumab, apparently shutting the door on one of the most closely watched experimental drugs over the past decade.
Walgreens says it won’t sell abortion pills in Indiana, even though it remains legal
The decision comes after Attorney General Todd Rokita and 19 other attorneys general threatened legal action if the pharmacy company sells the pills by mail.
In ninth try, Eli Lilly asks shareholders to end staggered terms for board members
The Weinberg Center for Corporate Governance at the University of Delaware, a leading voice for responsible corporate leadership, has generally supported the elimination of staggered terms, saying they can lead to entrenched boards and management that fails to perform.
Investors wary as Elanco pins hopes on new products
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
Under growing pressure, Lilly to cut price of popular insulins by 70%
The Indianapolis-based drugmaker also said it will expand a program that caps patient out-of-pocket costs at $35 or less a month.
Panel backs moving opioid antidote Narcan over the counter
The potential move represents the latest government effort to increase use of a medication that has been a key tool in the battle against the U.S. overdose epidemic that kills more than 100,000 people annually.